Target intelligence / Profile preview

TAR DNA-binding protein 43 messenger RNA (TDP-43 mRNA)

Target
TDP-43 mRNA
Molecular classification
Nucleic acid, Messenger RNA
01

Overview

TAR DNA-binding protein 43 (TDP-43) messenger RNA is the transcript of the TARDBP gene, which encodes a protein essential for RNA metabolism, including splicing, transport, and stability (UniProt Q13148). In healthy cells, TDP-43 protein levels are tightly controlled through an autoregulatory feedback loop where the protein binds to its own mRNA 3' untranslated region (UTR) to trigger degradation (Polymenidou et al., 2011). Pathologically, TDP-43 is the hallmark protein found in aggregates in nearly all cases of Amyotrophic Lateral Sclerosis (ALS) and about half of Frontotemporal Dementia (FTD) cases (Neumann et al., 2006). These "TDP-43 proteinopathies" involve the loss of nuclear TDP-43 and the accumulation of toxic cytoplasmic inclusions. Therapeutic strategies targeting the mRNA, such as antisense oligonucleotides (ASOs), aim to reduce the production of TDP-43 to mitigate gain-of-toxicity effects. One such candidate, BIIB105, is an investigational ASO designed to lower TDP-43 protein levels by promoting the degradation of its mRNA (NCT04408638). A significant challenge in targeting this mRNA is the narrow therapeutic window, as TDP-43 is vital for the survival of neurons and other cell types, and excessive knockdown can lead to neurodegeneration.

Other names
TARDBP mRNATAR DNA-binding protein 43 transcriptTDP-43 transcript
02

Mechanism of action

Antisense oligonucleotide-mediated degradation of mRNA via RNase H recruitment

03

Biological functions

Protein translationAutoregulation of gene expressionRNA metabolismSplicing regulation
04

Disease associations

Amyotrophic lateral sclerosisFrontotemporal dementiaLimbic-predominant age-related TDP-43 encephalopathyAlzheimer's disease
05

Safety considerations

Neurotoxicity due to loss of nuclear TDP-43 functionOff-target RNA bindingNarrow therapeutic indexPotential for systemic toxicity if not CNS-localized
06

Interacting drugs

BIIB105
07

Biomarkers

Neurofilament light chain (NfL)Cerebrospinal fluid TDP-43 protein levelsSTMN2 cryptic exon expressionUNC13A cryptic exon expression

Beyond the preview

Go deeper on TAR DNA-binding protein 43 messenger RNA (TDP-43 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TAR DNA-binding protein 43 messenger RNA (TDP-43 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call